|
BioFocus, ChanTest ink agreement
March 2013
SHARING OPTIONS:
SAFFRON WALDEN, United Kingdom—BioFocus and contract
research organization ChanTest, which boasts the most comprehensive validated
human ion channel-expressing cell lines library currently available
commercially, have established an agreement under which BioFocus will offer
ChanTest's cell line library—which consists of more than 200 products—and
Channel Panel profiling services. This agreement allows BioFocus broader
offerings in the areas of GPCR, ion channel and transporter targets for drug
discovery.
"With access to ChanTest's cell line collection and ion
channel profiling, we have further augmented our suite of integrated drug
discovery services, designed to deliver efficiency and success to our
partners," Kate Hilyard, vice president of Biological Sciences at BioFocus,
said in a press release regarding the deal. Back |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|